As of January 26, 2025, TriSalus Life Sciences (TLSI) has a market cap of $0.16 billion USD. According to our data, TriSalus Life Sciences is ranked No.7338 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 26, 2025 | $0.16 B |
3.19%
|
Dec 31, 2024 | $0.15 B |
-40.71%
|
Dec 29, 2023 | $0.26 B |
-15.75%
|
Dec 30, 2022 | $0.31 B |
1.52%
|
Dec 31, 2021 | $0.30 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Bristol-Myers Squibb
BMY
|
$121.02 B |
0.002 M
|
USA
|
Merck
MRK
|
$241.71 B |
0.003 M
|
USA
|
Pfizer
PFE
|
$147.85 B |
-0.000 M
|
USA
|
Johnson & Johnson
JNJ
|
$353.49 B |
-0.001 M
|
USA
|
Amgen
AMGN
|
$148.05 B |
0.004 M
|
USA
|
Gilead Sciences
GILD
|
$115.99 B |
0.004 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.26 B |
1.229 B
|
USA
|
Biogen
BIIB
|
$21.30 B |
0.001 M
|
USA
|
Moderna
MRNA
|
$16.50 B |
-0.000 M
|
USA
|
Eli Lilly
LLY
|
$706.33 B |
0.008 M
|
USA
|
Novartis
NVS
|
$199.87 B |
-0.003 M
|
Switzerland
|
Sanofi
SNY
|
$131.58 B |
0.000 M
|
France
|
AstraZeneca
AZN
|
$214.16 B |
0.006 M
|
UK
|
Market Cap | = | TLSI Stock Price | * | TLSI Shares Outstanding |
= | $5.17 | * | 30.49 M | |
= | $0.16 B |